Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer
Status:
Not yet recruiting
Trial end date:
2023-10-02
Target enrollment:
Participant gender:
Summary
This single-arm, Phase II clinical trial is to evaluate the efficacy and safety of
nab-paclitaxel plus S-1 in locally advanced pancreatic cancer who were borderline resectable
or unresectable .